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Background: Soil-transmitted helminths have been shown to have the immune regulatory
capacity, which they use to enhance their long term survival within their host. As these parasites
reside in the gastrointestinal tract, they might modulate the immune system through altering
the gut bacterial composition. Although the relationships between helminth infections or the
microbiome with the immune system have been studied separately, their combined interactions
are largely unknown. In this study we aim to analyze the relationship between bacterial
communities with cytokine response in the presence or absence of helminth infections.
Results: For 66 subjects from a randomized placebo-controlled trial, stool and blood
samples were available at both baseline and 21 months after starting three-monthly
albendazole treatment. The stool samples were used to identify the helminth infection status
and fecal microbiota composition, while whole blood samples were cultured to obtain
cytokine responses to innate and adaptive stimuli. When subjects were free of helminth
infection (helminth-negative), increasing proportions of Bacteroidetes was associated with
lower levels of IL-10 response to LPS {estimate [95% confidence interval (CI)] −1.96 (−3.05,
−0.87)}. This association was significantly diminished when subjects were helminth-infected
(helminth positive) (p-value for the difference between helminth-negative versus helminthpositive was 0.002). Higher diversity was associated with greater IFN-γ responses to PHA
in helminth-negative (0.95 (0.15, 1.75); versus helminth-positive [−0.07 (−0.88, 0.73),
p-value = 0.056] subjects. Albendazole treatment showed no direct effect in the association
between bacterial proportion and cytokine responses, although the Bacteroidetes’ effect on
IL-10 responses to LPS tended downward in the albendazole-treated group [−1.74 (−4.08,
0.59)] versus placebo [−0.11 (−0.84, 0.62); p-value = 0.193].
1
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Conclusion: We observed differences in the relationship between gut microbiome
composition and immune responses, when comparing individuals infected or uninfected
with geohelminths. Although these findings are part of a preliminary exploration, the data
support the hypothesis that intestinal helminths may modulate immune responses, in
unison with the gut microbiota.
Trial Registration: ISRCTN, ISRCTN83830814. Registered 27 February 2008 —
Retrospectively registered, http://www.isrctn.com/ISRCTN83830814.
Keywords: helminth, gut microbiome, whole blood cytokine, interleukin-10, Bacteroidetes, diversity, randomized
controlled trial

INTRODUCTION

bacterial profiling techniques or confounders such as ethnicity,
anthelminthic treatment, and environmental differences.
As it has been shown that changes in both gut microbiota
and helminth infection status might affect the host’s immune
response, it is suspected that the presence of helminth might
directly or indirectly affect the immune system by altering the
gut microbial community (Zaiss et al., 2015). For instance, the
transfer of the microbiota of Heligmosomoides polygyrus bakeriinfected mice to uninfected mice induced similar protection
against allergic airway inflammation as observed with helminth
infection (Wilson et al., 2005). In humans, studies on the
triangular relation between helminth with the microbiome and
immune system are still in infancy.
To our knowledge, the number of longitudinal studies analyzing
the association between gut microbiota and immune responses
in helminth-endemic areas is still limited. To understand the
interaction of the gut microbial community and helminths and
their common effect on immune responses, we used data from a
household cluster-randomized, double blind, placebo-controlled
trial of albendazole treatment in a helminth-endemic area. In
this study, it has been shown that deworming reduced helminth
prevalence and consequently increased several whole blood
cytokine responses (Wammes et al., 2016). Helminth infection
and anthelminthic treatment separately did not change the gut
microbiota (Martin et al., 2018). However, when subjects remained
infected while treated with albendazole, a decrease of Bacteroidetes:
Firmicutes ratio and an increase of Actinobacteria: Firmicutes ratio
were observed, leading to the hypothesis that there is a cross-talk
between microbiome composition and immune response which
is disrupted by the presence of helminths and that removing
helminth by anthelminthic might affect this communication. Our
aim was to characterize the association between bacterial relative
abundance with the whole blood cytokine responses and the effect
of helminth infections and deworming on this interaction.

Diseases of modernity, such as allergy, autoinflammatory, and
metabolic diseases are increasingly observed in industrialized
countries. It has been speculated that this growing rate was
caused by changes in lifestyle, diet and environmental factors,
such as pollutant exposure or hygiene. Hygiene improvement
has dramatically decreased the prevalence of certain infectious
agents such as parasitic helminths while these may have
protective effects against autoinflammatory diseases (Wammes
et al., 2016). Studies analyzing the capacity of helminths to
modulate the immune system have been carried out in recent
decades. However, it has become clear that this is an interplay
with several other factors, such as diet, environment and also
other gut inhabitants, such as the microbiota.
Early studies showed that gut microbiota is involved in
developmental aspects of the immune system and that disturbance
can lead to autoinflammatory disorders (Round and Mazmanian,
2009). Already in 1963, it was reported that the immune system
of germ-free mice failed to respond to molecular patterns of
pathogenic and beneficial microorganisms, causing morphological
tissue defects in the intestinal wall (Abrams et al., 1963). In healthy
humans, the role of gut microbiota and immune response was
studied more recently. It was found that certain bacteria are
beneficial for development and function of the immune system and
simultaneously the immune system can influence the composition
or function of gut microbiota, all relating to inflammatory
disorders [reviewed in Belkaid and Hand (2014)].
The presence of parasitic helminths in the gastrointestinal tract
may exert a direct influence on the host’s gut microbiome as they
share the same niche. Although in animal models helminths were
shown to increase microbial abundance and diversity (Reynolds
et al., 2015), the findings in human studies are not consistent.
Several studies analyzing the effect of helminth on gut microbiota
have indicated a higher diversity of gut microbiota in helminthpositive subjects compared to helminth-negative subjects (Lee
et al., 2014; Ramanan et al., 2016). A study in Ecuador showed
that this difference in diversity might be related to specific
helminth species since they did not find any alterations in
Trichuris trichiura-infected children (Cooper et al., 2013). This
might be influenced by different factors among which are different

MATERIALS AND METHODS
Participants

Stool samples from 150 subjects from the immunoSPIN study
(Wiria et al., 2010) taking place in Ende subdistrict, Indonesia,
were analyzed for the fecal microbiome. From these 150 subjects,
66 subjects were included in this study based on the complete
stool data and available cytokine measurements before and 21
months after the first treatment. The microbiome composition

Abbreviations: AscAg, Ascaris antigen; BMI, Body mass index; IFN, interferon;
IL, interleukin; LPS, lipoposaccharide; PHA, Phytohaemagglutinin; TNF, Tumor
necrosis factor.
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for these subjects are representative of these 150 subjects (Table
S1). Four different helminth species were found namely Ascaris
lumbricoides, hookworms (Necator americanus and Ancylostoma
duodenale) and T. trichiura. Details on sample collection and
measuring the infection status using PCR are described elsewhere
(Wiria et al., 2010). T. trichiura infection was assessed only by
microscopy, since at that time there was no real-time PCR data
available for this species. For this manuscript, we defined a
helminth-infected subject as a participant with a positive realtime PCR (cycle of threshold (Ct) value ≤ 30) and/or positive
microscopy for one or more species of helminths, as described
previously (Martin et al., 2018). Subjects with a positive real-time
PCR with a Ct above 30 were regarded as uninfected.

blood was diluted 1:4 and cultured in 96-well plates. Plates were
incubated for 24 (innate responses) or 72 (adaptive responses)
hours, after which supernatants were harvested and stored
in freezers. Cytokine levels were measured by Luminex bead
technology in samples obtained at before and 21 months after
the start of treatment.
The analyses carried in this manuscript are limited to
innate responses [interleukin (IL)-10 and tumor necrosis
factor-alpha (TNF-α)] to lipopolysaccharide (LPS) from E.
coli and adaptive responses [interferon-gamma (IFN-γ) and
IL-5) to Ascaris antigen (AscAg) and general T cell stimulator
phytohemagglutinin (PHA)]. The AscAg was a homogenate
of adult worm A. lumbricoides obtained from infected human
(Wammes et al., 2014).

Microbiome Composition

Statistical Method

The amplification and pyrosequencing of the 16S rRNA gene
followed the protocols developed by the Human Microbiome
Project (HMP) (A framework for human microbiome research.
Nature, 2012) at the McDonnell Genome Institute, Washington
University School of Medicine in St. Louis and have been described
previously elsewhere (Martin et al., 2018; Rosa et al., 2018). Briefly,
the V1–V3 hypervariable region was PCR — amplified and the PCR
products were sequenced on the Genome Sequencer Titanium FLX
(Roche Diagnostics, Indianapolis, Indiana), generating on average
6,000 reads per sample. Details of the filtering and analytical
processing of 16S rRNA data for this cohort has been previously
described in Rosa et al. (2018). The assembled contigs count data
as a result of RDP classification was organized in a matrix format
with taxa in columns and subjects in rows. The entries in the table
represent the number of reads for each taxon for each subject. Our
work is focused at a phylum level of gut bacteria. Five bacterial
phyla have average relative abundances larger than 1%, namely
Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria and an
unclassified category, which consists of sequences which could not
be categorized into a phylum. The remaining bacterial phyla which
had lower relative abundance were pooled together into a pooled
category. In the analysis, we retained the count for the three most
abundant bacterial phylum proportions, namely Actinobacteria,
Bacteroidetes, and Firmicutes. The proportion for each phylum was
obtained by dividing each sequence count by the total sequence per
person at each time point. Along with bacterial proportions, we
computed at a phylum level the bacterial diversity within samples
(Shannon index) and between samples (Bray-Curtis dissimilarity)
using R package vegan (Oksanen et al., 2017). The Shannon index
represents not only the presence of taxa but also the abundance of
corresponding taxa. The higher diversity index means that there
was not a single taxon dominating the community and the total
bacterial abundance is spread out over all taxa. The Bray Curtis
dissimilarity measures the percentage of similarity between one
sample from the other with values range from 0 (completely
similar) to 1 (completely dissimilar).

All parameters of interest were described as means or frequency
(± standard deviation). Prevalence rates were calculated and
compared using the Pearson chi-square test, while the Student
t-test was used to compare continuous variables.
To study the relationship between cytokines and microbiome
over the two time points, a linear mixed effect regression model
was fitted with helminth status and treatment as covariates. All
models have been adjusted with age and sex, however, since both
covariates were not significantly associated with the cytokine
responses in any model, they are not included in the final analysis.
The correlation between observations from the same subjects
was modeled by including a subject-specific random effect.
The microbiome was included in the model either as a bacterial
proportion or by the Shannon diversity index. The cytokine
responses were log10-transformed [log10(concentration + 1)] to
obtain normally distributed variables. First, we analyzed the
main effect of bacterial proportion and diversity on cytokine
responses. Second, to allow for different effect sizes of bacterial
proportion or diversity on cytokine responses in helminthpositive versus -negative subjects, an interaction term between
bacterial categories and infection was included in the model.
The p-value for this interaction term indicated the statistical
evidence for different effect sizes in helminth-positive or
-negative groups. Due to limited sample size, we restricted the
analysis into estimating the general effect of helminth infection
on the relationship between bacterial proportion and cytokine
responses. In the same manner, due to the limitation of sample
size, the direct treatment effect cannot be estimated. This means
that the estimates for the infection effect on the relationship
between bacterial proportions and diversity on cytokine
responses were obtained from data of subjects who were
infected at any time point, regardless of their randomization
arm. However, as treatment removes helminth infection, the
analysis of treatment effect on the relationship between bacterial
proportion and cytokine responses is viewed as a proxy to
understand the role of helminth in this relationship.
For this purpose, a linear mixed effect model was fitted with
bacterial proportion or diversity, treatment, and time as covariates.
This model was able to characterize three different associations,
namely the association between bacterial proportion or diversity

Whole Blood Cytokine Responses

The method to obtain and assess the cytokines responses were
described elsewhere (Wiria et al., 2010). In brief, heparinized
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on cytokines at pre-treatment, the difference of the association
at pre-treatment, and at post-treatment in the placebo group
(time effect), as well as the difference of the association at posttreatment between albendazole and placebo group.
For each outcome separately, these models were fitted on
subjects who at least had an observation at pre-treatment. The
lme4 package in statistical software R was used for model fitting.
The significance of the covariate effect was obtained from the
likelihood ratio test. Bonferroni correction was used to adjust for
multiple testing. We have applied Bonferroni correction for the
number of non-correlated cytokine per stimulatory condition
resulting in dividing the alpha cut-off level for significance by 2
(LPS responses) and 3(AscAg responses) and 2(PHA responses).
The statistical analyses were performed in R (R Core Team, 2017)
with mainly lme4 and lmerTest packages (Bates et al., 2015;
Kuznetsova et al., 2017). The full record was created using the
knitr package in R (Xie, 2017) and is available online at https://
github.com/Helminths_GutMicrobes_Cytokine/.

purpose, we used observations at both pre-treatment and posttreatment. Regardless of the randomization arm, we fitted the
linear mixed model on each cytokine responses as outcomes.
The predictors were bacterial proportions and its interaction
with helminth infection. A similar analysis was performed to
estimate the association between bacterial diversity and cytokine
responses. Figure 1 illustrates the associations between bacterial
proportions or diversity and cytokine responses when subjects
were helminth-positive or -negative.
In the innate immune response to LPS, the Bacteroidetes
proportion showed a significant negative association with IL-10
levels in helminth-negative subjects {estimated effect [95%
confidence interval (CI)]: −1.96 (−3.05, −0.87), p-value = 0.001;
Figure 1B} which shows that a unit increase of Bacteroidetes
proportion will reduce the concentration of IL-10 to LPS almost
twice as much. This association was significantly different from
that of helminth-negative subjects (p-value for the difference =
0.002, Figure 1) in which the association was absent [−0.03 (−0.59,
0.53)]. The bacterial diversity had no significant association with
IL-10 response to LPS (Figure 1). With regard to the helminthspecific cytokine responses, none of IFN-γ and IL-5 responses
to AscAg were significantly associated with bacterial proportions
or diversity (Figure 1). In the adaptive responses (PHA), none
of the cytokine responses were significantly associated with the
bacterial proportion in uninfected subjects (Figure 1). Although
not significant, we noticed lower levels of IFN-γ to PHA with
higher Firmicutes proportions [−1.57 (−3.08, −0.05), p-value =
0.045; Figure 1]. This association between Firmicutes proportion
with IFN-γ to PHA in uninfected subjects was however
significantly different from that in subjects who were infected
(p-value for the difference = 0.009, Figure 1). At the same time,
there was a significantly increasing concentration of IFN-γ to
PHA among those who were uninfected when bacterial diversity
was higher [0.95 (0.15, 1.75), p-value 0.022; Figure 1], although
this association was not significantly different from the helminthpositive group [−0.07 (−0.88, 0.73), p-value for the difference =
0.056; Figure 1]. A similar negative association of Firmicutes was
observed in IL-5 responses to PHA in uninfected subjects [−1.52
(−3.02, −0.02), p-value = 0.05; Figure 1]. Conversely increasing
bacterial diversity led to slightly higher levels of IL-5 to PHA
in the uninfected subjects [0.85 (0.07, 1.63), p-value = 0.034;
Figure 1]. Both observations were not significantly different
from the effects in those who were helminth-positive.

RESULTS
The Effect of Bacterial Proportions and
Diversity on In Vitro Cytokine Responses

Since it is hypothesized that gut bacteria are associated with certain
cytokine responses and thereby possibly immune disorders, we set
out to explore this relationship by using data from the ImmunoSPIN
trial. For 66 subjects, cytokine responses were measured at pretreatment and 21 months after the start of anthelmintic treatment.
At baseline, 40 out of 66 (60.6%) individuals in Ende were infected
with one or more helminth species, and hookworm was the most
dominant species (31.8%) followed by A. lumbricoides (25.7%)
and T. trichiura (22.7%). The baseline characteristics such as
age, gender, BMI and helminth prevalence were similar between
the two treatment arms (Table 1). Three-monthly albendazole
treatment for 21 months reduced the infection prevalence from
65.4% to 19.2% versus a slight increased of helminth infections
from 57.5% to 65% in the placebo group (Table S2).
We analyzed proportions of three bacterial phyla (Actinobacteria,
Bacteroidetes, and Firmicutes) as these were most abundant in
our study population. For the cytokine responses, we selected
outcomes representative of different parts of the immune system.
We have opted for the pro- and anti- inflammatory (TNF and
IL-10 respectively) immune response to LPS to represent the innate
responses, and the Th1 and Th2 signature cytokines (IFN-gamma
and IL-5 respectively) for the adaptive response to a helminth
antigen (AscAg) and T-cell stimulatory PHA. When fitting the linear
mixed model, no direct effect was observed of bacterial proportions
or Shannon diversity on whole blood cytokine responses (Table 2).

The Effect of Albendazole on the
Relationship Between Bacterial Proportion
and Diversity and In Vitro Cytokine
Responses

We further investigated whether deworming affects the
relationship between bacterial proportions or diversity and
cytokine responses. For this purpose, we fitted the linear mixed
model on all subjects (n = 66) to characterize the association
between bacterial proportions and cytokine responses at two
time points and in the two randomization arms. These analyses
were irrespective of the infection status. A similar model was
applied for the diversity index.

Interference by Helminth Infection in
the Effect of Bacterial Proportions and
Diversity on In Vitro Cytokine Responses

To elucidate the possible role of helminth infections in the
interplay of bacteria and immune responses, we conducted
analyses in helminth-positive and -negative groups. For this
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TABLE 1 | Characteristics of the participants at baseline.
Characteristics

Albendazole

Placebo

N

Result

N

Result

26
26

40
40

10
16

12 (46.1)
27.3 (16.1)
10 (38.4)
16 (61.5)
−0.52 (0.98)
23.39 (3.44)

17
23

22 (55.0)
26.7 (15.7)
17 (42.5.0)
23 (57.5)
−0.83 (0.64)
23.49 (4.89)

A. lumbricoidesa
Hookworm
N. americanusa
A. duodenalea
T. trichiurab
Any helminth

26
26
26
26
26
26

9 (34.6)
11 (42.3)
10 (38.5)
2 (7.7)
5 (19.2)
17 (65.4)

40
40
40
40
40
40

8 (20.0)
10 (25.0)
10 (25.0)
2 (5.0)
10 (25.0)
23 (57.5)

Abundance of bacterial phyla [mean % (SD)]

26

Gender, female [N (%)]
Age [mean (SD)]
Children [< = 18 years old; N (%)]
Adults [>18 years old; N (%)]
zBMI [mean (SD)]
BMI [mean (SD)]
Parasite infection [N (%)]

40
9.1 (5.8)
8.0 (10.5)
72.4 (10.4)
8.5 (7.3)
1.4 (0.8)
0.6 (0.8)

Actinobacteria
Bacteroidetes
Firmicutes
Proteobacteria
unclassified bacteria#
pooled*
Diversity Index, median (IQR)

9.6 (7.7)
7.1 (12.1)
71.6 (12.8)
8.6 (6.2)
2.5 (3.1)
0.6 (0.9)

26

40

Shannon index
Bray-Curtis

0.85 (0.71, 0.99)
0.19 (0.12, 0.26)

0.84 (0.73, 1.00)
0.19 (0.13, 0.28)

Cytokine responses (pg/mL, median, IQR)
LPS

TNF-α
IL-10
IFN-γ
IL-5
IL-10
IFN-γ
IL-5
IL-10

AscAg

PHA

25
25
23
22
23
23
23
23

664.00 (294.00,1029.00)
242.00 (132.00, 400.00)
28.50 (12.10, 111.80)
32.55 (9.55, 58.42)
8.28 (3.22, 22.45)
2,449.00 (354.00, 5,424.00)
490.00 (276.00, 747.50)
101.00 (54.05, 167.00)

40
40
37
37
37
37
37
37

550.50 (343.00, 840.00)
213.50 (142.00, 380.20)
17.40 (7.74, 60.90)
18.90 (12.00, 62.00)
6.61 (2.55, 10.30)
2299.00 (997.00, 3829.00)
515.00 (333.00, 870.00)
83.20 (36.80, 140.00)

Diagnosed by real-time PCR; bdiagnosed by microscopy; #unclassified bacteria represents the category of sequences that could not be assigned to a phyla, and the;
*pooled category consists of the remaining 13 phyla with average relative abundance less than 1%.
a

TABLE 2 | The association between bacterial proportion and diversity on cytokine responses.
Estimated effect (95% CI)

LPS
AscAg

PHA

IL-10
TFN-α
IFN-γ
IL-5
IL-10
IFN-γ
IL-5
IL-10

Actinobacteria

Bacteroidetes

Firmicutes

Shannon

0.20 (−0.58, 0.98)
0.55 (−0.35, 1.44)
−1.03 (−2.45, 0.39)
−1.02 (−2.78, 0.74)
−0.04 (−0.56, 0.48)
−0.57 (−2.12, 0.98)
−0.04 (−1.55, 1.46)
0.46 (0.02, 0.91)

−0.39 (−0.90, 0.12)
−0.06 (−0.66, 0.54)
0.15 (−0.80, 1.10)
0.09 (−1.10, 1.28)
0.15 (−1.21, 1.51)
−0.26 (−1.28, 0.75)
0.32 (−0.67, 1.32)
0.33 (−0.80, 1.46)

0.24 (−0.23, 0.71)
−0.14 (−0.70, 0.41)
−0.20 (−1.13, 0.74)
0.39 (−0.74, 1.52)
−0.72 (−1.63, 0.18)
−0.03 (−1.05, 0.99)
−0.85 (−1.82, 0.11)
−0.03 (−0.78, 0.72)

−0.22 (−0.51, 0.07)
0.03 (−0.31, 0.37)
0.14 (−0.44, 0.71)
−0.48 (−1.16, 0.20)
0.30 (−0.57, 1.16)
0.45 (−0.18, 1.08)
0.61 (0.02, 1.20)
−0.46 (−1.19, 0.27)

Figure 2 displays the associations between the proportions of
three major bacterial phyla and diversity with cytokine responses,
before and after anthelminthic treatment. With regard to the
relationship between Bacteroidetes and IL-10 response to LPS,
no significant differences were observed between pre- versus
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post-treatment or between treatment groups (Figure 2). While
the estimated association between Bacteroidetes proportion and
IL-10 to LPS at pre-treatment [estimate (95% CI): −0.47 (−1.23,
0.29)] and post-treatment in placebo group [−0.11 (−0.84,
0.62)] were close to zero, the association at post-treatment in
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FIGURE 1 | The association between bacterial proportion and diversity on cytokines responses in helminth-negative and -positive subjects. The effect of bacterial
proportions on cytokine responses was analyzed for helminth-negative [helminth(−)] and helminth-positive [helminth(+)] groups by a linear mixed model. Estimated
effects ± 95% CI are shown for the effect of Actinobacteria (A), Bacteroidetes (B), Firmicutes (C) and diversity (D) on cytokine responses. For assessing statistical
significance modified Bonferroni correction was applied; *p-value ≤ 0.025 (for LPS and PHA responses).

the association between Actinobacteria with IL-5 responses to
AscAg. At pre-treatment, the increasing Actinobacteria proportions
were significantly associated with less IL-5 production in response
to AscAg [−3.65: (−6.34, −0.97), p-value = 0.009; Figure 2A]. This
association was significantly different to the effect of Actinobacteria
at post-treatment in placebo group [2.90 (−0.03, 5.84), p-value =
0.002]. Although the estimated association in albendazole group
was lower [−1.42 (−4.58, 1.73), this was not significantly different
between the treatment groups (p-value = 0.052)]. The effect of
Actinobacteria on IL-10 responses to PHA changed after treatment
[−0.65 (−2.33–1.02) vs 2.90 (1.07–4.73) for pre-treatment vs posttreatment placebo group, p-value 0.005] and was different between
placebo and albendazole groups as well [albendazole group −1.72
(−3.69–0.25), p-value for placebo vs albendazole 0.001; Figure 2A].

albendazole group was clearly lower [−1.74 (−4.08, 0.59); p-value
for the difference between placebo and albendazole was 0.193,
Figure 2B]. The association between IFN-γ in response to PHA
and bacterial diversity was also not significant at post-treatment
either in the placebo or in the albendazole group (Figure 2D).
The association between higher Actinobacteria proportion with
decreasing response of TNF-α to LPS was borderline significant
at pre-treatment [estimate (95% CI): −1.55 (−2.87, −0.22),
p-value = 0.024; Figure 2A]. This association was significantly
different to the effect of Actinobacteria at post-treatment when
subject received placebo [2.02 (0.57, 3.47); p-value < 0.001; Figure
2A], however no difference was observed when comparing
placebo and albendazole group [1.89 (0.29, 3.49), p-value for the
difference = 0.907; Figure 2A]. A similar result was obtained from
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FIGURE 2 | The association between bacterial proportion and diversity on cytokines responses at pre-treatment and post-treatment in two randomization arms.
After deworming, comparisons were made for all subjects pre-treatment versus post-treatment (placebo group) and post-treatment placebo versus albendazole
groups. Estimated effects of a linear mixed model ± 95% CI are depicted for the effect of Actinobacteria (A) Bacteroidetes (B) Firmicutes (C) and diversity (Shannon
index) (D). *p-value ≤ 0.025 (for LPS and PHA responses) for statistical significance between placebo and albendazole groups.

DISCUSSION

Moreover, while the association between Firmicutes and IL-5
response to PHA at pre-treatment was not significantly different
compared to the association at post-treatment in placebo group,
there was a significant difference of this association between
albendazole and placebo group at post-treatment [estimate (95%
CI) for placebo −1.52 (−2.83, −0.22) versus albendazole 1.84
(−0.73, 4.41), p-value = 0.024; Figure 2C].
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This study aimed to analyze the effect of helminth infections
on the relationship between gut microbiota and the immune
system. We found a negative association between proportions
of Bacteroidetes and IL-10 response to LPS in helminth-negative
subjects and the presence of helminths was shown to dampen
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this effect. Anthelminthic treatment partly recovered this
effect, although not statistically significant. To our knowledge,
this is the first time that the association between the gut
microbiome, presence of parasitic helminths and whole blood
cytokine responses was analyzed in a longitudinal study using a
randomized placebo-controlled anthelminthic trial.
IL-10 was already marked as a key anti-inflammatory
cytokine involved in the induction of immune suppression by
helminths (Yazdanbakhsh et al., 2002). Our observation that
helminths counteract the suppressed IL-10 response to LPS in
subjects with higher Bacteroidetes proportions supports the so
called “old friends hypothesis” (Rook, 2009), stating that certain
infectious agents such as helminths may have protective effects
against immune dysfunction and inflammatory diseases, possibly
through IL-10. This is strengthened by our observed gradient of
the relative abundance of Bacteroidetes from rural to urban areas,
where immune-related diseases are more prevalent (Bach, 2002).
In contrast, a recent meta-analysis indicated that inflammatory
bowel disease (IBD) patients displayed lower proportions of
Bacteroidetes (Zhou and Zhi, 2016), however, this was only
found when measuring by real-time quantitative PCR (not by
conventional culture) and mainly in Asian studies. Furthermore,
a member of the Bacteroidetes family, gut inhabitant Bacteroides
fragilis, was shown to protect mice from experimental colitis,
mediated by polysaccharide A (PSA) possibly through IL-10
induction (Mazmanian et al., 2008). However, although B.
fragilis is the most well-known pathogen of the Bacteroidetes,
it is the least common species in the Bacteroidetes phylum in
the human gut (Wexler, 2007). It could therefore be that other
factors or species play a dominant role in the general effect of
Bacteroidetes on IL-10 responses. Further studies are therefore
needed to assess the translation of our findings to a clinical
setting, for example prevalence or activity of IBD or other autoimmune diseases. Moreover, since we have measured systemic
whole blood cytokine responses, we are not sure whether this is
representative for the gut responses.
A trend of negative association between Firmicutes and
concentration of IFN-γ to PHA was seen in helminth-negative
subjects only. In subjects with helminth, this association
was positive, although this difference fell short of statistical
significance. Parallel to this trend, the bacterial diversity was
positively associated with IFN-γ responses to PHA in subjects
who did not carry helminths, and in helminth-positive subjects,
this association was dampened. Since a similar opposite trend
was observed in the relationship between Firmicutes compared
to bacterial diversity on IL-5 responses to PHA, we may
conclude that not the proportion of Firmicutes, but the total
bacterial diversity drove this association. Firmicutes was the most
abundant phyla in this population and the increasing proportion
of Firmicutes will obviously reduce diversity. This indicates
that analyzing single bacterial phyla without considering the
remaining phyla may lead to biased results as microbiome data is
compositional and thus correlated between phyla.
Although deworming removed most helminths, treatment
did not significantly alter the effects of bacterial proportions
on cytokine responses. Regarding the Bacteroidetes effect on
LPS to IL-10, we did observe a lower effect in the albendazole
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group compared to placebo. Although not significant, this
might point towards the idea that anthelminthic treatment
could restore the possibly detrimental- interaction of bacteria
with immune responses. Surprisingly, we found differences in
immune modulation by Actinobacteria in the pre- versus posttreatment group. Although there was a significant association of
time (in subjects receiving a placebo), these associations were
not significantly different in the albendazole group. The effect
of time could be explained by other factors such as diet and
possibly improved hygiene, resulting from increased awareness
during the presence of our medical team in the study area. In the
analysis of treatment’s effect on the association between bacterial
proportion and diversity, there was a significant difference
between the association of Firmicutes on the IL-5 response to
PHA in the albendazole group compared to the placebo group.
In subjects receiving albendazole, Firmicutes proportions were
positively associated with IL-5 levels, while we observed a
negative (non-significant) effect in helminth-negative individuals
over time. This result seems contradictory, but might be related
to the fact that small numbers were analyzed and not everyone in
the albendazole group lost their helminth infection. The analysis
of subjects who were infected at baseline and cleared their
infection would possibly reveal more clearly how the relationship
between bacterial communities and immunity are affected by
treatment. This analysis lacks statistical power in our study as
the sample size was small (n = 12 out of 17 subjects who were
successfully dewormed). Future research which involves larger
sample sizes needs to be conducted. With larger sample size, the
current statistical model can be extended to account for different
infection status at different time points as well as different
randomization arms. Thereby we would gain more insight in
the responses within individuals, and how these are affected by
worm infection and deworming. Another relevant thought in
this and similar research settings is that although albendazole
removes helminths effectively, the immunomodulatory effects
of helminths on cytokine responses are long-lasting and cannot
be easily corrected by short-term treatment. It was previously
reported by Endara et al. that the length of periodic treatment is
important for altering immune responses (Endara et al., 2010),
i.e. that studies with a longer period of treatment (up to 30
months) are more likely to show effects of deworming.
As significant associations between bacterial communities
and cytokine responses were only observed when subjects were
helminth-negative, clearly other factors than helminth and
treatment are also involved in the alteration of the microbiome
community and their interaction with the immune system.
For example, our study data lack information on diet. Dietary
intake was clearly shown to affect bacterial communities in the
gastrointestinal tract (Wu et al., 2011). This might also be related
to changes in social economic status leading towards a more
high-fat diet when moving from rural to urbanized areas. Recent
articles reported inconsistencies with regard to the direction of
Bacteroidetes to Firmicutes ratio in rural to urban comparisons
of microbiome profiles from different geographical areas. Studies
comparing children from Bangladesh to USA children showed
the direction of increasing Bacteroidetes: Firmicutes in the USA,
as observed in our data (Lin et al., 2013), while studies in elderly
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Korean and children in Burkina Faso showed opposing results,
i.e. decreasing Bacteroidetes: Firmicutes ratios from rural to
urban (Park et al., 2015; Filippo et al., 2017). This could be caused
by different genera under Bacteroidetes or Firmicutes phyla which
might be affected by certain type of diet. Therefore, it will be
beneficial for future studies to also include dietary factors from
the study participants.
A further limitation is related to the statistical tools available
in analyzing this relationship. Here, we characterized the
association of three single bacterial proportions on cytokine
response in the helminth-positive and -negative group. Using this
approach, we first ignore the effect of compositional structure in
the microbiome data, namely when computing the p-value we
assumed that these bacterial categories are independent while
they are correlated. Secondly, the current statistical model ignores
the fact that microbiome is a variable measured with errors at
a different scale than the cytokine responses (Teixeira-Pinto
et al., 2009). In addition, we might as well ignore the possible
unobserved confounders. It is therefore important for future
studies in this field to develop a statistical method to characterize
the effects of helminth infection on both outcomes simultaneously
by accounting these unobserved errors with a joint model.
To conclude, our findings support the hypothesis for the role
of helminths in modulating the immune response, which might
be related to bacterial proportion and diversity. Deworming did
not show a particular effect on the observed associations. It is
therefore important to repeat such studies with a larger sample
size as well as using more advanced statistical models to further
analyze this relationship by considering the complex structure of
microbiome data and other possible confounders.

This study was nested within the ImmunoSPIN study, a
double-blind placebo-controlled trial conducted in Flores
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has been approved by the Ethical Committee of Faculty of
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ISRCTN83830814. The subjects gave their informed consent
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was obtained for children below 15 years old.
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